Skip to content

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF

TMEDNasdaqA

$33.01−0.63 (−1.87%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 30 prints from 33.63 to 33.01. Range 33.01 to 34.36. Use the arrow keys to read each point.33.2534.0034.2510 AM12 PM2 PM4 PM
Expense ratio
0.44%
Fund size
$33M
1Y total return
+22.4%
Yield · Last 12 months
Data unavailable
Holdings
111
Avg volume · 30D
0M sh
NAV per share
$33.81
52W range
low $27.57high $36.72
Launched
Filings
SEC EDGAR

The ETF.net TMED Grade

Based on 5 of 6 pillars

A

Score 70 out of 100

Rank
3 of 35
Six-pillar profile for TMED. Scores out of 100: Cost 82, Risk 56, Mission not scored, Tradability 61, Holdings 89, Durability 35. Strongest: Holdings (89). Weakest: Durability (35). Based on 5 of 6 pillars.

Score 70 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A82 out of 100
    Rank 7 of 35
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B56 out of 100
    Rank 12 of 35
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B61 out of 100
    Rank 10 of 35
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A89 out of 100
    Rank 1 of 35
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D35 out of 100
    Rank 29 of 35

TMED Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
111
Top-10 weight
39%
Largest holding
LLY.TO5.7%

Sectors

  • Health Care99.9%
  • Technology0.1%

Geography

  • United States93.37%
  • Germany2.12%
  • Denmark2.02%
  • Switzerland1.60%
  • Canada0.51%
  • Italy0.20%
  • China0.09%
  • United Kingdom0.05%
  • Other countries (1)0.04%
The fund’s holdings, weight-ordered — page 1 of 8.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001LLY.TOEli Lilly & Co Common Stock5.67%1,586$2M6
002ALNYAlnylam Pharmaceuticals Inc Common Stock USD.015.36%7,589$2M259
003UNH.BAUnitedHealth Group Inc Common Stock USD.015.21%4,531$2M7
004TMO.NEThermo Fisher Scientific Inc Common Stock USD1.03.60%1,801$1M6
005CORCencora Inc Common Stock USD.013.51%3,573$1M336
006PODDInsulet Corp Common Stock USD.0013.47%8,466$1M217
007GILDGilead Sciences Inc Common Stock USD.0013.20%6,979$1M492
008AAgilent Technologies Inc Common Stock USD.012.99%5,770$984K317
009ISRGIntuitive Surgical Inc Common Stock USD.0012.92%2,270$962K410
010ELANElanco Animal Health Inc Common Stock2.79%40,061$918K156
011WSTWest Pharmaceutical Services Common Stock USD.252.46%2,217$811K284
012DHRDanaher Corp Common Stock USD.012.35%3,518$773K331
013CYTKCytokinetics Inc Common Stock USD.0012.30%12,036$757K134
014WATWaters Corp Common Stock USD.012.14%1,628$706K282
015PCVXVaxcyte Inc Common Stock USD.0012.10%9,720$694K109

Showing 1–15 of 111 holdings

TMED Performance

Launched Jun 11, 2025

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
TMED$12,244
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. TMED $12,244. SPY $12,044. Use the arrow keys to read each point.$9,444$11,539$13,634Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for TMED. Periods over one year show the average yearly return.
PeriodTMED
Year to date+13.2%
1 month−0.5%
3 months−3.4%
1 year+22.4%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for TMED
YearReturn barTMED
2026 YTD+13.2%
2025+18.9%

History from Jun 12, 2025

TMED in the news

Filtered to TMED · US Active Sector

TMED Dividends

Last payment
$0.16 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 1 payment from 2025 to 2026 YTD. Dec 23, 2025 $0.16. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Dec 23, 2025Dec 26, 2025$0.16

TMED Risk

How much the fund’s monthly returns vary, scaled to a year.
15.2%
Annualised · 15 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.51
vs 3-month T-bills · 15 months to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−11.1%
16 months · trough Mar 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.46
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

TMED Cost

Expense ratio0.44%
  • The middle half of US Active Sector funds
  • Median 0.65%

6 of the 35 US Active Sector funds charge less.

TMED costs $44.00 a year on $10,000. The median US Active Sector fund costs $65.00.

Other funds in US Active Sector